OmniAb Showcases Multispecific Antibody Workflow and Launches OmniHub™ at AETC 2024

17 December 2024 | Tuesday | News


Presentations spotlighted a case study on multispecific antibody development and unveiled OmniHub™, a unified bioinformatics platform to streamline antibody discovery workflows.
Image Source : Public Domain

Image Source : Public Domain

Presentations included a case study of the workflow for building multispecifics and the launch of OmniHub, a bioinformatics tools platform

OmniAb, Inc. announced that two presentations featuring the Company’s technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San Diego.

In a presentation titled “Building Multispecifics from in vivo Derived Antibody Domains and Alternative Scaffolds,” Yasmina Abdiche, Ph.D., Vice President of Exploratory Research, provided an overview of building multispecifics ranging from traditional CD3 T cell engagers to next-generation NK cell engagers, facilitated by emerging targets such as NKp46.

“OmniAb’s technologies offer significant advantages in multispecifics, including naturally optimized human sequence immune repertoires across multiple host species, a variety of antibody modalities to support novel molecular formats, and artificial intelligence (AI)-augmented single B cell workflows for deep repertoire mining,” said Matt Foehr, Chief Executive Officer of OmniAb. “We have a strong track record of delivering candidates which lead to clinical-stage and approved bispecifics, where on-target specificity, developability, tunable affinity and broad epitope coverage are all important elements. Leveraging this foundation, our platform offers versatile multi-modality options, providing our partners with the flexibility to execute their campaigns effectively.”

“This case study presentation demonstrates how we discovered developable anti-NKp46 binders with broad epitope coverage and affinities, serving as building blocks for NK cell engager multispecifics. We enhanced high-throughput phenotypic screening with AI-guided next-generation sequencing workflow to explore the vast sequence space and identify high-quality leads, thereby avoiding extensive ex vivo engineering,” added Dr. Abdiche.

At AETC the Company also highlighted OmniHub, a high-dimensional unified bioinformatics portal, in a presentation titled “Design and Implementation of OmniHub, A Platform for Bioinformatics Tools Facilitating Antibody Discovery Workflows,” by Swetha Garimalla, Ph.D., Director of Computational Immunology. OmniHub is part of OmniAb’s ongoing commitment to enhancing the partner experience with its technologies and services. OmniHub enables scalable and secure data transfer, advanced visualization and comprehensive tool access.

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close